Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Item
http://www.wikidata.org/entity/Q28480907
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-AnalysisThe Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformTreatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided QualityEnhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosisPersistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosisPredictors of disability worsening in clinically isolated syndrome.Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis.Evaluation of the Adherence to Immunmodulatory Treatment in Patients with Multiple Sclerosis.RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology.The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
P2860

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Item
http://www.wikidata.org/entity/Q28480907
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Country, sex, EDSS change and ...... d clinically isolated syndrome
@ast
Country, sex, EDSS change and ...... d clinically isolated syndrome
@en
Country, sex, EDSS change and ...... d clinically isolated syndrome
@nl
type
label
Country, sex, EDSS change and ...... d clinically isolated syndrome
@ast
Country, sex, EDSS change and ...... d clinically isolated syndrome
@en
Country, sex, EDSS change and ...... d clinically isolated syndrome
@nl
prefLabel
Country, sex, EDSS change and ...... d clinically isolated syndrome
@ast
Country, sex, EDSS change and ...... d clinically isolated syndrome
@en
Country, sex, EDSS change and ...... d clinically isolated syndrome
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Country, sex, EDSS change and ...... d clinically isolated syndrome
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0038661
P407
P433
P478
P50
P577
P5875
P698
P921
P932